NASDAQ:MNRO • US6102361010
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MONRO INC (MNRO).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-10-30 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-21 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-31 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-29 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-28 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-04 | Stephens & Co. | Upgrade | Equal-Weight -> Overweight |
| 2025-04-01 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2025-04-01 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-02-27 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2025-01-30 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-27 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-15 | Stephens & Co. | Initiate | Equal-Weight |
| 2023-09-07 | Wells Fargo | Initiate | Equal-Weight |
| 2022-05-20 | BMO Capital | Maintains | Market Perform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.325B -2.49% | 1.277B -3.67% | 1.195B -6.38% | 1.192B -0.28% | 1.211B 1.59% | 1.232B 1.73% | 1.276B 3.57% | |
| EBITDA YoY % growth | 156.8M -14.41% | 143.629M -8.40% | 81.937M -42.95% | 105.84M 29.17% | 108.17M 2.20% | 118.53M 9.58% | N/A | |
| EBIT YoY % growth | 79.8M -21.76% | 71.425M -10.49% | 12.565M -82.41% | 41.469M 230.04% | 45.062M 8.66% | 56.271M 24.87% | 69.516M 23.54% | |
| Operating Margin | 6.02% | 5.59% | 1.05% | 3.48% | 3.72% | 4.57% | 5.45% | |
| EPS YoY % growth | 1.36 -26.88% | 1.32 -2.94% | 0.49 -62.88% | 0.56 14.91% | 0.68 21.23% | 0.95 39.72% | 1.23 29.41% |
All data in USD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 47.87% | 0.23 3.16% | 0.23 8.47% | 0.21 31.75% | 0.07 252.17% |
| Revenue Q2Q % growth | 290.81M -1.42% | 303.12M 0.69% | 303.51M 5.05% | 318.01M 8.39% | 314.21M 8.05% |
| EBITDA Q2Q % growth | 18.456M -59.46% | 29.693M 212.03% | 29.784M -31.71% | 28.713M -55.64% | 24.123M 30.71% |
| EBIT Q2Q % growth | 1.596M 106.69% | 14.27M 334.90% | 14.138M 10.89% | 12.682M -31.71% | 8.077M 406.08% |
All data in USD
11 analysts have analysed MNRO and the average price target is 26.14 USD. This implies a price increase of 48.17% is expected in the next year compared to the current price of 17.64.
MONRO INC (MNRO) will report earnings on 2026-05-26, before the market open.
The consensus EPS estimate for the next earnings of MONRO INC (MNRO) is -0.05 USD and the consensus revenue estimate is 290.81M USD.
The number of analysts covering MONRO INC (MNRO) is 11.